Correlation Between Axim Biotechnologies and PsyBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axim Biotechnologies and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axim Biotechnologies and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axim Biotechnologies and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Axim Biotechnologies and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axim Biotechnologies with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axim Biotechnologies and PsyBio Therapeutics.

Diversification Opportunities for Axim Biotechnologies and PsyBio Therapeutics

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Axim and PsyBio is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Axim Biotechnologies and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Axim Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axim Biotechnologies are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Axim Biotechnologies i.e., Axim Biotechnologies and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between Axim Biotechnologies and PsyBio Therapeutics

Given the investment horizon of 90 days Axim Biotechnologies is expected to generate 0.95 times more return on investment than PsyBio Therapeutics. However, Axim Biotechnologies is 1.06 times less risky than PsyBio Therapeutics. It trades about -0.05 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about -0.21 per unit of risk. If you would invest  0.50  in Axim Biotechnologies on September 1, 2024 and sell it today you would lose (0.23) from holding Axim Biotechnologies or give up 46.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Axim Biotechnologies  vs.  PsyBio Therapeutics Corp

 Performance 
       Timeline  
Axim Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Axim Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak forward indicators, Axim Biotechnologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Axim Biotechnologies and PsyBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axim Biotechnologies and PsyBio Therapeutics

The main advantage of trading using opposite Axim Biotechnologies and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axim Biotechnologies position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.
The idea behind Axim Biotechnologies and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm